The Technical Take: GW Pharmaceuticals Higher After Q4 Report

GW Pharmaceuticals PLC- ADR GWPH shares are trading higher by $5.00 at $117.32 in Monday's session.

The catalyst for the rally is a Q4 earnings beat. The company also announced positive Phase 3 Trial data for a few different drugs in the pipeline.

Despite the EPS beat, the issue opened lower, but immediately found support at $110.00 and began to move higher. It has continued to make new highs for the session, with current one standing at $117.70.

If the rally continues, the next daily resistance level comes in at November 29 high ($118.81).

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!